A detailed history of Lazard Asset Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 4 shares of BIO stock, worth $1,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$1,281
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $359 - $486
-1 Reduced 20.0%
4 $1,000
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $351 - $456
1 Added 25.0%
5 $2,000
Q2 2022

Aug 09, 2022

SELL
$463.67 - $597.16 $1.08 Million - $1.39 Million
-2,322 Reduced 99.83%
4 $1,000
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $2.63 Million - $3.68 Million
-5,008 Reduced 68.28%
2,326 $1.31 Million
Q4 2021

Feb 09, 2022

SELL
$708.84 - $794.68 $1.33 Million - $1.49 Million
-1,875 Reduced 20.36%
7,334 $5.54 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $1.39 Million - $1.74 Million
-2,110 Reduced 18.64%
9,209 $6.87 Million
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $6.39 Million - $7.19 Million
11,077 Added 4577.27%
11,319 $7.29 Million
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $12,581 - $15,234
23 Added 10.5%
242 $138,000
Q4 2020

Feb 11, 2021

SELL
$510.68 - $643.45 $174,141 - $219,416
-341 Reduced 60.89%
219 $127,000
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $224,942 - $265,122
495 Added 761.54%
560 $287,000
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $2,009 - $2,958
6 Added 10.17%
65 $29,000
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $18,880 - $24,135
59 New
59 $20,000
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $1.16 Million - $1.26 Million
-4,026 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$224.3 - $317.41 $903,031 - $1.28 Million
4,026 New
4,026 $1.23 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.